Cargando…
The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial
BACKGROUND: Restless legs syndrome (RLS) affects approximately 30% of patients with end-stage kidney disease and is associated with impaired sleep and health-related quality of life. Medications used to treat RLS in patients receiving dialysis may have an increased risk of adverse events with dose t...
Autores principales: | Collister, David, Pohl, Kayla, Herrington, Gwen, Lee, Shun Fu, Rabbat, Christian, Tennankore, Karthik, Zimmermann, Deborah, Tangri, Navdeep, Wald, Ron, Manns, Braden, Suri, Rita S., Nadeau-Fredette, Annie-Claire, Goupil, Remi, Silver, Samuel A., Walsh, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705292/ https://www.ncbi.nlm.nih.gov/pubmed/33294203 http://dx.doi.org/10.1177/2054358120968959 |
Ejemplares similares
-
Effects of restless legs syndrome (RLS) on sleep
por: Bogan, Richard K
Publicado: (2006) -
The biopsychosocial effects of restless legs syndrome (RLS)
por: Becker, Philip M
Publicado: (2006) -
Pramipexole in peritoneal dialysis patients with restless legs syndrome (RLS): a protocol for a multicentre double-blind randomised controlled trial
por: Ma, Tian-tian, et al.
Publicado: (2020) -
Leg restlessness and hyperparathyroidism in Parkinson's disease, a further clue to RLS pathogenesis?
por: Marano, Massimo, et al.
Publicado: (2023) -
Aripiprazole, a Novel Option in the Management of Restless Legs Syndrome (RLS) Patients with Augmentation and/or Severe RLS Symptoms: A Report of 4 Cases
por: Lee, Elliott Kyung, et al.
Publicado: (2023)